[1]
2024. The Treatment of Lichen Sclerosus with Topical Roflumilast 0.3% Case Study. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), 1997–2000. DOI:https://doi.org/10.25251/skin.8.6.15.